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A high-yield yeast expression system for site-directed
mutagenesis of the Neurospora crassa plasma mem-
brane H1-ATPase has recently been reported (Mahanty,
S. K., Rao, U. S., Nicholas, R. A., and Scarborough, G. A.
(1994) J. Biol. Chem. 269, 17705–17712). Using this sys-
tem, each of the eight cysteine residues in the ATPase
was changed to a serine or an alanine residue, produc-
ing strains C148S and C148A, C376S and C376A, C409S
and C409A, C472S and C472A, C532S and C532A, C545S
and C545A, C840S and C840A, and C869S and C869A,
respectively. With the exception of C376S and C532S, all
of the mutant ATPases are able to support the growth of
yeast cells to different extents, indicating that they are
functional. The C376S and C532S enzymes appear to be
non-functional. After solubilization of the functional
mutant ATPase molecules from isolated membranes
with lysolecithin, all behaved similar to the native en-
zyme when subjected to glycerol density gradient cen-
trifugation, indicating that they fold in a natural man-
ner. The kinetic properties of these mutant enzymes
were also similar to the native ATPase with the excep-
tion of C409A, which has a substantially higher Km.
These results clearly indicate that none of the eight
cysteine residues in the H1-ATPase molecule are essen-
tial for ATPase activity, but that Cys376, Cys409, and
Cys532 may be in or near important sites. They also dem-
onstrate that the previously described disulfide bridge
between Cys148 and Cys840 or Cys869 plays no obvious
role in the structure or function of this membrane trans-
port enzyme.
The plasma membrane H1-ATPase of Neurospora crassa is
an electrogenic (1) proton pump (2), that belongs to the P-type
family of ion translocating ATPases that form an aspartyl
phosphate intermediate in their reaction cycle (3, 4). This
ATPase is closely related to the yeast and plant plasma mem-
brane H1-ATPases and homologous with numerous mamma-
lian cation translocating ATPases including the Na1/K1-, H1/
K1-, and Ca21-ATPases (5–9).
Many studies involving chemical modification of the cysteine
residues in the Neurospora H1-ATPase have been reported
(10–17). The sulfhydryl reagent, N-ethylmaleimide was origi-
nally shown to have no effect on the H1-ATPase activity (10),
but subsequent studies reported inhibition by N-ethylmaleim-
ide when treatments were carried out at elevated pH values
(11–16). More recent studies of the effect of N-ethylmaleimide
on the ATPase have been interpreted to indicate that Cys532
and Cys545 residues are near important sites (15, 16), but
similar studies with methyl methanethiosulfonate have shown
that neither of these cysteines nor cysteines at positions 376,
409, and 472 play a covalent role in the reaction cycle of the
enzyme. In another study (17), the chemical states of the eight
cysteine residues in the H1-ATPase molecule were determined,
establishing the presence of a disulfide bridge between Cys148
and either Cys840 or Cys869. These studies provided valuable
information as to the structure of the ATPase molecule but
could not address the possible function of the disulfide bridge.
Site-directed mutagenesis is a powerful tool for exploring
structure-function relationships in the H1-ATPase by identify-
ing individual amino acid residues that are important for its
structure and activity. We have recently developed a yeast
expression system for such studies of the Neurospora H1-
ATPase (18), and in this article, this system is used to further
probe the roles of the eight cysteine residues in its structure
and molecular mechanism.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis and Plasmid Constructions—For mu-
tagenesis, we began with the plasmid pSKMHA2 (18), which contains
the full-length N. crassa plasma membrane H1-ATPase cDNA. The
NotI site at the 39 end of the H1-ATPase cDNA in pSKMHA2 was
removed by partially digesting with NotI, filling in the ends with DNA
polymerase “Klenow” fragment, and religating with a SpeI linker (GAC-
TAGTC), which resulted in plasmid pSKMHA9. pSKMHA9 was di-
gested with either NotI and EcoRI, EcoRI and XbaI, XbaI and SmaI,
SmaI and SacI, or SacI and SpeI, and each of the resulting ATPase
cDNA cassettes was subcloned either into pBluescript or M13 mp18/19
vectors. Single stranded “U”-DNA was isolated from Escherichia coli
CJ236 (dut2,ung2), and amino acid substitutions were made using the
oligonucleotide-directed site-specific in vitro mutagenesis technique of
Kunkel (19). The mutagenic oligonucleotides were designed to singly
substitute each Cys (TGC) codon with a Ser (AGC) or an Ala (GCC)
codon or the active site Asp (GAC) codon to an Ala (GCC) codon. The
mutated cassettes were completely sequenced to verify that only the
planned changes had occurred. The cassettes were then ligated into the
N. crassa H1-ATPase cDNA in place of the wild type cassette in pSK-
MHA9. In all cases, mutagenesis was confirmed again by sequencing
the mutated region prior to yeast transformation. Quaprep plasmid
spin kits (Quazen Inc., Chatsworth, CA) were routinely used for plas-
mid isolation from E. coli. Sequence analysis of single-stranded and
double-stranded DNA was performed by the dideoxynucleotide chain
termination method (20) using version 2.0 sequencing kit from U. S.
Biochemical Corp.
Strains and Media—E. coli strains MC1061 and HB101 were used
for normal cloning, and strain JM83 was used for transformation with
Bluescript plasmids. Strains JM103 and CJ236 were used for mutagen-
esis and for making single-stranded uracilated DNA templates, respec-
tively. Saccharomyces cerevisiae strain RS-72 was transformed with the
different mutant constructs as described previously (18). Transforma-
tions with Neurospora wild type H1-ATPase plasmid pSKMHA9 gen-
erated strain SKM9. The construction of strain SKM3 with the expres-
sion plasmid but no ATPase insert has been described (18).
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Transformation with the plasmid containing the ATPase insert with
the codon for Cys148 changed to an Ala codon generated strain C148A,
and all other strains were similarly named. Yeast transformants were
selected and propagated on galactose medium and then transferred
to glucose medium in order to express only the mutant Neurospora
ATPases (18). The cells were maintained on agar plates at 4 °C and
were recultured every 2 weeks or kept at 280 °C in 15% (w/v) glycerol
for 6–8 months. The growth media and cell culture procedures for
membrane isolation were essentially as described (18). All cultures used
for membrane preparations were tested for revertants by plating
roughly 106 cells on glucose medium and inspecting for large colonies
after 24 h. Essentially no revertants were seen.
Transformations—Transformations of E. coli cells were routinely
done using standard protocols (21). Transformation of the yeast cells
was carried out according to the procedure of Ito et al. (22) as described
previously (18).
Growth Tests—Drop tests for growth were carried out for the differ-
ent mutants and control strains as described (18). To ascertain the
growth rates of the various strains in liquid glucose medium, the
transformants were grown for 48 h in galactose medium (A610 nm ap-
proximately 3.0) at 30 °C, and the cells were then transferred to glucose
medium at a density of about 5 3 106 cells/ml, after which the growth
was scored every 2–6 h as the A610 nm.
Isolation of Membranes and Purification of the Expressed H1-ATPase
Molecules—Membranes from different yeast transformants were pre-
pared essentially as described (18), except that cell homogenization was
carried out in a medium bead beater chamber and all of the solutions
contained 2 mg/ml chymostatin. For membrane preparations from
transformants that do not grow on glucose medium (strains C376S,
C532S, and D378A), cells transferred from a master galactose plate
were grown for 48 h at 30 °C in 50 ml of galactose medium, diluted 1:10
in galactose medium, and grown for another 24 h, harvested aseptically,
and transferred into an equal volume of double strength glucose me-
dium (all components present in concentrations twice that previously
described (18)) and grown for an additional 24 h as above. In certain
experiments the total membrane preparations were fractionated by
sucrose density gradient centrifugation as described by Villalba et al.
(23). Solubilization of the membrane proteins with lysolecithin and
purification of the various expressed H1-ATPase molecules by glycerol
density gradient centrifugation were carried out as described (18) in 12-
ml 20–40% (w/v) linear glycerol gradients.
H1-ATPase Assay and Protein Estimation—The plasma membrane
ATPase activity was measured as described (18). For kinetic studies
of the H1-ATPase activity, equimolar concentrations of MgSO4:
Na2ATP in the range of 0.25–14 mM were added and the assay
mixture contained 2 mM of extra Mg21 (as MgSO4) to compensate for
the 2 mM EDTA present to complex traces of vanadate. For the
vanadate sensitivity of the ATPase activities, a range of vanadate
concentrations from 0.1 to 10 mM was added to the assay tubes and
the EDTA was omitted. The specific activity, Km, and Vmax values
were calculated by linear regression analyses of Lineweaver-Burk
double reciprocal plots. The protein contents of the membranes and
gradient fractions were determined by the Lowry procedure as mod-
ified by Bensadoun and Weinstein (24).
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis, Stain-
ing, Immunoblotting, and Densitometric Analysis—SDS-PAGE1 was
performed essentially as described by Laemmli (25) with minor modi-
fications (26). Disaggregation of membrane suspensions or glycerol
gradient fractions and electrophoresis of the samples was done as
described (18) except that only high resolution gels were used. Silver
staining and immunoblotting were performed as described (18).
For densitometric analysis of the amounts of mutant Neurospora
ATPases present in the glycerol gradient fractions, aliquots of the
pooled peak activity fractions (numbers 9, 10, 11, and 12 from the top)
were first subjected to SDS-PAGE as described above, and the gels
were silver-stained and photographed. The photographs were then
scanned using a Bio-Rad Image Densitometer (Model GS-670) and the
ATPase region was integrated using the Molecular Analyst TM/PC
Software (Image Analysis Software Version 1.1.1). The amounts of
the mutant ATPases were calculated by comparision with 5, 10, and
20 ng samples of purified native Neurospora H1-ATPase (27) present
in the same gel.
Materials—SpeI linker (phosphorylated 10-mer) was obtained from
New England Biolabs. Disodium ATP, lysolecithin, and chymostatin
were from Sigma. The sources of all other reagents were as described
(18).
RESULTS
As described previously (18), in the yeast expression system
used for these studies, both the wild type yeast H1-ATPase and
the plasmid-encoded Neurospora H1-ATPase are produced
when the cells are grown in medium containing galactose as
the carbon source. When the cells are transferred to glucose
medium, synthesis of the yeast ATPase ceases, which limits
growth to only a few doublings unless a functional Neurospora
H1-ATPase is present. Fig. 1 shows these features with several
control yeast strains used in this investigation. Growth of the
parent strain SKM9 with an unmutated Neurospora H1-
ATPase is shown along with the growth of strain SKM3, which
contains the expression plasmid with no ATPase cDNA, and
strain D378A, which contains a cDNA in which the codon for
the active site Asp378 of the Neurospora enzyme has been
changed to an Ala codon. The parent strain grows well,
whereas both of the other control strains grow for only a few
doublings and then stop growing as expected in glucose me-
dium. Growth in glucose medium is thus a convenient screen-
ing assay for the functionality of the Neurospora H1-ATPase
mutants we produce.
Table I shows the growth rates of the control strains and
the various cysteine mutant ATPase strains calculated from
growth curves similar to those shown in Fig. 1. Both strain
C148S and strain C148A grow at about the same rate as the
unmutated ATPase control strain. Strain C376S does not
grow any more than the negative control strains and strain
376A grows only very slowly. Strain C409S grows about the
same as the unmutated ATPase strain, and significantly
better than strain C409A. On the other hand, strain C472S
grows substantially slower than strain C472A. Interestingly,
strain C532S does not grow any more than the negative
controls, whereas strain C532A grows well. Strains C545S
and C840S both grow well whereas both strains C545A and
C840A grow somewhat more slowly than their serine coun-
terparts. Strain C869S grows at an intermediate rate
whereas strain C869A grows at a rate about the same as that
of the wild type strain SKM9.
To ascertain the amounts of the ATPase systhesized in the
various strains, membranes were isolated from each of the
mutants grown in glucose medium and analyzed by SDS-PAGE
1 The abbreviation used is: PAGE, polyacrylamide gel
electrophoresis.
FIG. 1. Growth of several control yeast strains. Shown are the
growth characteristics of several control yeast transformants in glucose
medium assessed as described under “Experimental Procedures.” Un-
mutated Neurospora H1-ATPase producing strain, SKM9 (E); no
ATPase, plasmid control strain SKM3 (M); active site aspartate ATPase
mutant D378A (Ç).
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and silver staining as described under “Experimental Proce-
dures.” The results indicated the presence of substantial
amounts of the mutant ATPases in the membranes of all of the
mutants except C376S, C532S, and D378A (data not shown).
The levels of mutant Neurospora ATPase present in the mem-
branes of these three strains were substantially lower, which
precluded further analysis of these enzymes.
When solubilized with the detergent, lysolecithin, the na-
tive Neurospora H1-ATPase is a hexamer (28) that migrates
to the bottom third of a 20–40% glycerol gradient (29). This
sedimentation behavior provides a simple but effective assay
for proper folding of the recombinant Neurospora H1-ATPase
molecules produced in yeast. To assess the extent to which
the various cysteine mutants fold properly, each of the mu-
tant ATPases was solubilized from the membranes with ly-
solecithin and the solubilized extract was subjected to glyc-
erol density gradient centrifugation as described (18). The
results indicated that all Cys 3 Ala and the six remaining
Cys 3 Ser mutant H1-ATPase molecules migrated quantita-
tively to a position identical to that of the SKM9 recombinant
ATPase and the native enzyme (data not shown), providing
strong evidence that each of these mutant ATPases folds
correctly in theoretical yields.
In addition to providing a simple folding assay, lysolecithin
solubilization and glycerol density gradient centrifugation pro-
duces substantially purified preparations of the mutant
ATPases useful for further analysis. Fig. 2 shows the H1-
ATPase region of SDS-PAGE analyses of the pooled peak glyc-
erol gradient fractions from two different membrane prepara-
tions from each of the various Cys 3 Ser and Cys 3 Ala
mutants and the control strains SKM9 and SKM3. In the
region between the 97.4 and 116.2 kDa standards, three bands
are routinely seen. The uppermost of these bands is the yeast
H1-ATPase, the middle one is the recombinant Neurospora
H1-ATPase, and the lower one is an unidentified band of no
interest in these studies. The yeast ATPase band represents
residual amounts of this enzyme present when the cells are
transferred to glucose medium. The analyses in Fig. 2 show
that the amounts of the Neurospora ATPase synthesized are
generally reproducible for each strain. To quantitate the
amount of each mutant H1-ATPase present in the pooled peak
glycerol gradient fractions, the gels of Fig. 2 were subjected to
densitometric analysis as described under “Experimental Pro-
cedures.” The amounts of the mutant ATPases produced in the
various strains are listed in Table II. The amounts were vari-
able from strain to strain in the range of roughly half to 1.6
times that of strain SKM9. The analyses also showed that none
of the partially purified ATPase preparations contained more
residual yeast H1-ATPase than that of the control strain
SKM3, which contained only the yeast ATPase (Fig. 2, lanes 2).
With this information, the kinetic characteristics of the var-
ious partially purified Cys 3 Ser and Cys 3 Ala mutant
H1-ATPases could be determined. Importantly, the pooled gra-
dient fractions from the control strain SKM3 showed no
ATPase activity in the assay system used. Therefore, since
none of the other preparations contained more yeast ATPase
than strain SKM3, the ATPase activities measured reflect only
that of the Neurospora enzymes. Table II shows the kinetic
constants determined for the ATPases from all of the viable
mutant and control strains. For all mutant ATPases analyzed,
the Km and Vmax values are not substantially altered except in
the case of mutant C409A, which shows a greater than 10-fold
increase in its Km with no difference in Vmax. Although not
shown, the vanadate sensitivities of all of the mutant enzymes
were comparable to that in the wild type ATPase strain SKM9
(I50% about 1 mM).
DISCUSSION
The results obtained in these studies allow several important
conclusions regarding the functions of the eight cysteine resi-
dues in the Neurospora H1-ATPase molecule. First, it is clear
that none of the cysteines is essential for the catalytic mecha-
nism of the enzyme. Replacement of each cysteine with an
alanine residue produces functional ATPase molecules in
strains C148A, C376A, C409A, C472A, C532A, C545A, C840A,
and C869A, since all of these mutant ATPases are able to
support the growth of yeast cells in glucose medium to some
degree. Moreover, except for the C409A enzyme all of these
mutant ATPases exhibit kinetic properties similar to that of
the wild type strain SKM9.
Second, although none of the cysteines is essential, several
appear to be in or near important sites of action in the H1-
TABLE I
Growth rates of the control and various mutant strains




















a Growth was measured in liquid glucose medium as described under
“Experimental Procedures.” The growth rates were calculated from the
data of Fig. 1 and similar data from experiments with the cysteine
mutant strains as the slope of the plots between 30 and 40 h 3 1000.
FIG. 2. SDS-PAGE analysis of the pooled peak glycerol gradi-
ent fractions from strains SKM9, SKM3, and the various Cys 3
Ser and Cys 3 Ala H-ATPase mutants. Panels A and B show
silver-stained SDS-PAGE gel analyses of the pooled peak glycerol gra-
dient fractions from two different experiments carried out on different
days. Three mg of membrane protein from each strain was solubilized
with lysolecithin (5 mg of lysolecithin/mg of membrane protein) and the
solubilized extracts were layered on the top of 20–40% (w/v) linear
glycerol gradients and centrifuged overnight as described under “Ex-
perimental Procedures.” One-ml fractions were collected and aliquots
were assayed for ATPase activity. The peak fractions (9–12 from the
top) were pooled and analyzed by SDS-PAGE. Lane 1 contained 10 ml of
SKM9 pooled peak glycerol gradient fractions, lane 2 contained 10 ml of
SKM3 pooled glycerol gradient fractions 9–12, and lanes 3–16 con-
tained 10 ml of the pooled peak glycerol gradient fractions from mutants
C148S, C409S, C472S, C545S, C840S, C869S, C148A, C376A, C409A,
C472A, C532A, C545A, C840A, and C869A, respectively. Lanes 17–19
contained 5, 10, and 20 ng of purified native N. crassa H1-ATPase,
respectively. The numbers to the left of panels A and B indicate the
molecular masses of the SDS-PAGE standards used in kDa. Only the
approximate 100-kDa H1-ATPase regions of the gels are shown.
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ATPase molecule. Cys376 is clearly near the active site of the
ATPase as it is only one residue removed from the active site
aspartate at position 378, and the mutagenesis results reported
here suggest that it may serve an important function. Although
the C376A enzyme folds correctly and exhibits kinetic charac-
teristics nearly the same as those of the wild type ATPase, it
only weakly supports the growth of the cells. This suggests the
possibility that the C376A ATPase may be uncoupled with
respect to ATP hydrolysis and proton translocation. Alterna-
tively, the rate of synthesis of this mutant ATPase may be
somehow slowed. Obviously, a more detailed investigation of
the C376A ATPase will be necessary before the defect in this
interesting mutant will be understood.
Cys409 is also important and appears to be a part of the
MgATP binding site. Replacement of this cysteine with an
alanine causes a 10-fold increase in the Km without alteration
of the Vmax or vanadate sensitivity (Table II). On the other
hand, replacement of Cys409 with a serine does not change the
Km near as drastically. This suggests that the -SH group of
Cys409 may be involved in binding with some part of the sub-
strate, MgATP, in the native enzyme.
Cys532 may also be in or near an important site, since the
mutant C532S ATPase totally failed to support growth on
glucose medium (Table I). However, mutant C532A supported
cell growth and displayed normal kinetic characteristics.
Cys532 has been reported to be protected against reaction with
N-ethylmaleimide by MgADP and may thus be in or near the
nucleotide binding site (15). If so, our results suggest that some
aspect of the substrate binding and phosphoryl transfer reac-
tions occurs less efficiently when the cysteine -SH is replaced
with an -OH by conversion to serine than when it is removed
entirely by replacement with an alanine.
The third conclusion that can be drawn from these experi-
ments is that the previously detected disulfide bridge linking
Cys148 and either Cys840 or Cys869 (17) plays no obvious role in
the structure or function of the H1-ATPase molecule. Replace-
ment of Cys148, Cys840, or Cys869 with a serine or an alanine
residue does not affect the ability of the ATPase to support cell
growth in any major way, and the folding and kinetic proper-
ties of these mutant ATPases are normal. These results pre-
clude an important structural role for the disulfide bridge in
the Neurospora H1-ATPase as made in yeast and assayed in
these experiments.
In our original description of the yeast expression system
used in these studies, it was pointed out that in certain cases
measuring the activities of expressed Neurospora H1-ATPase
molecules in the presence of the endogenous yeast H1-ATPase
may be problematic. However, from the studies reported here,
it is clear that the yeast H1-ATPase is inactive in the ATPase
assay procedure employed, because no ATPase activity could be
detected in the appropriate glycerol gradient fractions pro-
duced with the plasmid control strain SKM3. Thus, contami-
nation by the endogenous yeast H1-ATPase does not appear to
be a problem for future mutagenesis studies of the Neurospora
H1-ATPase using this expression system. However, as can be
seen from our results with mutants C376S and C532S, a prob-
lem does remain for mutants that are totally unable to support
cell growth. Whereas a negative growth test by a particular
mutant is a strong indication that an important residue has
been altered, the low amounts of the mutant ATPases produced
makes further analysis of such interesting mutants more dif-
ficult than those that support growth. Encouragingly, prelim-
inary results of membrane fractionation studies with mutants
D378A, C376S, and C532S indicate that these ATPases are
enriched in a light membrane fraction distinct from the plasma
membrane. Thus, although more work will be required to study
such ATPase mutants, detailed analyses of their activities and
partial reactions should neverthless be possible.
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